tiprankstipranks
Advertisement
Advertisement

FR:NANO Stock Latest News

Nanobiotix announces EUR 75M global follow-on offering
The FlyNanobiotix announces EUR 75M global follow-on offering
15h ago
NBTX
Nanobiotix files EUR75M ordinary shares offering
PremiumThe Fly
Nanobiotix files EUR75M ordinary shares offering
17h ago
NBTX
Nanobiotix price target raised to EUR 60 from EUR 34 at H.C. Wainwright
PremiumThe Fly
Nanobiotix price target raised to EUR 60 from EUR 34 at H.C. Wainwright
3d ago
NBTX
Nanobiotix announces FDA acceptance of NANORAY-312 study protocol amendment
PremiumThe Fly
Nanobiotix announces FDA acceptance of NANORAY-312 study protocol amendment
17d ago
JNJ
NBTX
Nanobiotix price target raised to $30 from $3.50 at UBS
PremiumThe Fly
Nanobiotix price target raised to $30 from $3.50 at UBS
20d ago
NBTX
PremiumRatingsNanobiotix: Platform Expansion Potential and Risk-Adjusted NBTXR3 Valuation Support Buy Rating
29d ago
NBTX
Nanobiotix price target raised to EUR 34 from EUR 32 at H.C. Wainwright
Premium
The Fly
Nanobiotix price target raised to EUR 34 from EUR 32 at H.C. Wainwright
1M ago
NBTX
Premium
Company Announcements
Nanobiotix Earnings Call: Deeper J&J Ties, Lower Loss
1M ago
Nanobiotix price target raised to $36 from $26 at Guggenheim
PremiumThe Fly
Nanobiotix price target raised to $36 from $26 at Guggenheim
2M ago
NBTX
Nanobiotix: Late-Stage NBTXR3 Pipeline and Partnerships Underpin Buy-Rated Risk-Reward Profile
PremiumRatings
Nanobiotix: Late-Stage NBTXR3 Pipeline and Partnerships Underpin Buy-Rated Risk-Reward Profile
2M ago
NBTX
Nanobiotix price target raised to $37 from $26 at Leerink
PremiumThe Fly
Nanobiotix price target raised to $37 from $26 at Leerink
2M ago
NBTX
Robust Phase 2 CONVERGE Data for JNJ-1900 Underpin Buy Rating and €32 Price Target on Nanobiotix
PremiumRatings
Robust Phase 2 CONVERGE Data for JNJ-1900 Underpin Buy Rating and €32 Price Target on Nanobiotix
2M ago
NBTX
Nanobiotix price target raised to EUR 32 from EUR 23 at H.C. Wainwright
PremiumThe FlyNanobiotix price target raised to EUR 32 from EUR 23 at H.C. Wainwright
2M ago
NBTX
Nanobiotix presents first data from CONVERGE study
Premium
The Fly
Nanobiotix presents first data from CONVERGE study
2M ago
JNJ
NBTX
Nanobiotix says ‘no such intention’ for company to acquire control
Premium
The Fly
Nanobiotix says ‘no such intention’ for company to acquire control
2M ago
NBTX
Nanobiotix initiated with a Buy at TD Cowen
PremiumThe Fly
Nanobiotix initiated with a Buy at TD Cowen
3M ago
NBTX
Nanobiotix: Differentiated Radiotherapy Enhancer, J&J Partnership, and Multi-Indication Pipeline Undervalue Long-Term Upside, Supporting Buy Rating
PremiumRatings
Nanobiotix: Differentiated Radiotherapy Enhancer, J&J Partnership, and Multi-Indication Pipeline Undervalue Long-Term Upside, Supporting Buy Rating
3M ago
NBTX
Undervalued Royalty Stream and De‑Risked Partnership Economics Underpin Nanobiotix Buy Rating
PremiumRatings
Undervalued Royalty Stream and De‑Risked Partnership Economics Underpin Nanobiotix Buy Rating
4M ago
NBTX
Strategic Financial and Operational Advancements Propel Nanobiotix to a Buy Rating
PremiumRatings
Strategic Financial and Operational Advancements Propel Nanobiotix to a Buy Rating
6M ago
NBTX
Nanobiotix price target raised to EUR 23 from EUR 20 at H.C. Wainwright
PremiumThe FlyNanobiotix price target raised to EUR 23 from EUR 20 at H.C. Wainwright
7M ago
NBTX
Nanobiotix’s Strategic Financing and Clinical Expansion Signal Strong Buy Opportunity
Premium
Ratings
Nanobiotix’s Strategic Financing and Clinical Expansion Signal Strong Buy Opportunity
7M ago
NBTX
Nanobiotix enters royalty-based financing pact with HealthCare Royalty for $71M
Premium
The Fly
Nanobiotix enters royalty-based financing pact with HealthCare Royalty for $71M
7M ago
NBTX

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >